LinkedIn co -founder and risk capitalist Reid Hoffman became the billionaire of its business social work company, and Airbnb And Zynga also supports nuclear fusion to start Helion Energy.

Now, Hoffman is studying medical care. He describes it as "wonderful and horrible", and his latest startup company Manas AI.

Hoffman (Hoffman) and oncologist and Pulitzer award -winning writer Siddhartha Mukherjee unveiled the company on Monday. Manas will use artificial intelligence to try to accelerate the process of drug discovery, starting with new therapies for aggressive cancers such as prostate cancer, lymphoma and triple -negative breast cancer.

Traditionally, the development of new drugs is an expensive and complicated process. According to a report from Deloitte, developing a single drug may take more than 10 years and cost billions of dollars. Manas said it will use its proprietary chemical library and AI -driven filter to identify candidate drugs faster, and ideally, the decades of discovery process will be reduced to several years.

In an interview this week, Hoffman told CNBC: "Most people have friends, family members, etc., they died of cancer or severe cancer." "If we can have a huge impact on this, and this is AI that can What is under the huge influence is why AI can be beneficial to humans. "

Manas raised $ 24.6 million seed funds, led by the catalyst and Hoffman. He is GreyLock and he is a partner. In recent years, Hoffman (Hoffman) is deep in AI. When the project was still a non -profit organization, he was an early investor in Openai. He helped Aid AI with DeepMind co -founder Mustafa Suleyman. Last year, Suleyman joined Hoffman, Microsoft, as a member of the board of directors, and was a chief executive of a new department called Microsoft AI. Several inflection employees joined him.

Manas still MicrosoftAnd it will use its Azure cloud computing platform. Hoffman sold Linkedin to Microsoft at a price of $ 27 billion.

Hoffman has been working with Mukherjee for about a year, although the process has been flourishing in the past few months. Hoffman said that since its baseline, this week can publicly share his ambitions, and the basic resources have been in an orderly manner.

The company's forward route is very long, and the market is very competitive in the market. Other startups and major pharmaceutical companies Yililai,,,,, Boring and MortarAnd also exploring how to use AI to accelerate drug development.

Hofman said he was confident in Manas's method, although he was "completely happy" about the booming development of many companies.

He said: "We also brought something that startups usually bring. This is a very hard willingness to quickly abandon the remarkable thing." "Life is like this week. "" "

Hofman said that after Manas started Monday, five different potential strategic partners have contacted the company.

Hofman said the company is in the "fast construction" and "learning and deployment" model. According to the company's website, its early initiative is called Project COSMOS, which is to formulate the basic rules of drug constraints. Hofman refused to share any other details about the project.

There are currently only four employees of Manas-including Hoffman and Mukji, but Hoffman said it will grow. He said. In the end, Manas was about two areas.

Huffman said: "This is not only the best science, but also the best in AI, because none of them are enough." "You need to put these two people together."

As a AI guy, Hofman pays close attention to the sudden appearance of China in the United States this week

Deepseek began to buzz in January. At that time, the startup released its open source reasoning R1, which is comparable to OPENAI O1. According to reports, the model was developed by OPENAI, Anthropic, Google and others with a small part of the cost of competitors model.

Hofman said that although DeepSeek may encourage American companies to improve the pace and share their plans faster, the new revelation does not show that large models are a bad investment.

He said: "The game started, but I don't think this is 'oh, my God, we lost!' As American technology."

watch: Reid Hoffman, co -founder of linkedin